delta sleep-inducing peptide dsip overview Buy Delta sleep-inducing peptide (DSIP) -

Each receptor contributes distinct metabolic effects

Exceptional safety margin No dependence or tolerance naturally occurring endogenous peptide Tolerability in clinical trials No tolerance develops with repeated doses No withdrawal symptoms upon stopping Peptide naturally present in the human body Research considerations Researcher's notes Outstanding safety profile for a bioactive peptide No serious adverse events were reported in the published studies

Dependence could result in the inability to sleep without it, which makes it hard to stop using the peptide and could lead to insomnia or insomnia-filled nights

Prolonged standing or walking may lead to back pain or leg discomfort, including numbness or tingling